HeartBeam commences pilot study of new 12-lead ECG patch
HeartBeam has initiated a pilot study to evaluate its on-demand 12-lead electrocardiogram (ECG) patch in patients with suspected coronary artery…
All articles by Salong Debbarma
Salong Debbarma
-
-
Inhibrx announces positive interim results from HexAgon trial
Inhibrx Biosciences has reported positive interim data from the Phase II segment of its HexAgon study assessing INBRX-106 in treatment-naïve,…
-
Partner Therapeutics secures FDA approval for Bizengri
Partner Therapeutics has received the US Food and Drug Administration (FDA) approval for Bizengri (zenocutuzumab-zbco) to treat adults with advanced,…
-
CoMira concludes lease agreement for plant in Sudair Industrial City, Saudi Arabia
Co-Diagnostics' joint venture (JV) CoMira Diagnostics has completed a lease agreement for its planned manufacturing facility in the Kingdom of Saudi…
-
Day One concludes patient enrolment for tovorafenib’s FIREFLY-2 trial
Day One Biopharmaceuticals has concluded patient enrolment in the Phase III FIREFLY-2 trial assessing tovorafenib for paediatric low-grade glioma (pLGG).…
-
BMS’ Sotyktu secures EC approval for psoriatic arthritis
Bristol Myers Squibb (BMS) has secured approval from the European Commission (EC) for Sotyktu (deucravacitinib) to treat active psoriatic arthritis…
-
Microsure receives CE mark for MUSA-3 system and appoints new CEO
Dutch medical technology company Microsure has secured CE mark approval for its MUSA-3 system and appointed Alex Joseph as its…
-
MEDSIR reports PHERGain and PHERGain-2 trial results for breast cancer
MEDSIR has reported data from the PHERGain and PHERGain-2 trials, which focused on targeted therapies in early human epidermal growth…
-
Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn
Angelini Pharma has signed a definitive agreement to purchase Catalyst Pharmaceuticals for a total equity value of nearly €3.5bn ($4.1bn), marking…
-
Halozyme and Oruka sign agreement for Hypercon technology
Halozyme Hypercon has signed an exclusive global collaboration and licence agreement with Oruka Therapeutics for the development of ORKA-001 using…